<![CDATA[New real-world data in obese, antidepressant-naive patients with MDD shows bupropion edging SSRIs on remission, though rates stay low.]]>
<![CDATA[Investigational depression drugs target SIRT6 epigenetics, histamine H3, and AMPA.]]>
<![CDATA[The ASCp meeting spotlights a fast-acting psychedelic for postpartum depression, vasopressin-targeting drugs, and ketamine’s promise for Parkinson symptoms.]]>
<![CDATA[Study finds most bipolar depression outpatients have multiple comorbidities; many seek care, but substance use and phobias often go untreated.]]>
<![CDATA[Experts discuss ketamine safety, monitoring, neurotoxicity concerns, and key considerations for psychiatrists treating depression at the ASCP Annual Meeting.]]>